<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-04-20T16:07:38Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/aaa.000004">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/aaa.000004</identifier>
									<datestamp>2018-02-15</datestamp>
									<setSpec>PTZ.AAA:VOL2</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										Castalagin: Some aspects of the mode of Anti-Herpes Virus Activity
										</dc:title><dc:creator>N Vilhelmova-Ilieva</dc:creator><dc:creator> D Deffieux</dc:creator><dc:creator> S Quideau</dc:creator><dc:creator> AS Galabov</dc:creator><dc:description>&lt;p style="text-align: justify;"&gt;Castalagin, a nonahydroxytriphenoyl-bearing C-glucosidic ellagitannin, manifested a marked virucidal effect on HSV-1. This effect was markedly temperature and time dependent, being clearly higher at 37 °C than at room temperature: Δlog of 3.13 with 10 μM concentration of castalagin (MNC). Castalagin also suppressed HSV-1 particle attachment to MDBK cells. A significant effect (Δlog = 1.7) was found after 30 min of substance exposure and was increased at 60 min (Δlog = 3.2). Castalagin effect on the production of virions during the HSV-1 replication cycle was studied using a time-of-addition experimental scheme at the one-step viral replication cycle design. The highest sensitivity to castalagin was recorded 0–3 h post virus inoculation. A substantially weaker effect was found at the 6–12 h time intervals. At 18–24 h, HSV-1 replication was unsusceptible to castalagin. Evidently, castalagin target is located in the earlier stages of the HSV-1 replication cycle.&lt;/p&gt;</dc:description>
										<dc:publisher>Annals of Antivirals and Antiretrovirals - Peertechz Publications</dc:publisher>
										<dc:date>2018-02-15</dc:date>
										<dc:type>Research Article</dc:type>
										<dc:identifier>https://doi.org/10.17352/aaa.000004</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © N Vilhelmova-Ilieva et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
